Investment focus and strategy

CapMan Life Science invests principally in Nordic medtech companies and healthcare service providers. For new investments we seek profitable companies that have the best products or services in their target market. In the medtech sector we are mainly interested in companies that market and sell medical products and equipment used for the diagnosis and treatment of diseases.

Where do we invest?

• Healthcare companies (services, products, and medical technology)
• Primarily Nordic companies
• Companies with net sales in the range of €2–20 million
• Life Science fund investments are typically in the order of €2–7 million

What do we look for?

• Successful business concepts and approved products and/or services
• Products or services that are in demand today and will continue to be over the long term, and typically provide better treatment results at a lower cost
• Substantial growth potential through organic growth or local and/or international mergers and acquisitions
• Experienced, entrepreneurially minded management teams

–